Thromb Haemost 1996; 75(04): 661-667
DOI: 10.1055/s-0038-1650339
Original Article
Schattauer GmbH Stuttgart

Characterization of Fcγ Receptors on Human Megakaryocytes

Zhanhe Wu
The Centre for Thrombosis and Vascular Research, the University of New South Wales and the Department of Haematology, Prince of Wales Hospital, Randwick, New South Wales, Australia
,
Boban Markovic
The Centre for Thrombosis and Vascular Research, the University of New South Wales and the Department of Haematology, Prince of Wales Hospital, Randwick, New South Wales, Australia
,
Colin N Chesterman
The Centre for Thrombosis and Vascular Research, the University of New South Wales and the Department of Haematology, Prince of Wales Hospital, Randwick, New South Wales, Australia
,
Beng H Chong
The Centre for Thrombosis and Vascular Research, the University of New South Wales and the Department of Haematology, Prince of Wales Hospital, Randwick, New South Wales, Australia
› Author Affiliations
Further Information

Publication History

Received 21 June 1995

Accepted after resubmission 18 December 1995

Publication Date:
10 July 2018 (online)

Preview

Summary

Megakaryocyte and platelet Fcγ receptors (FcR) are of importance in the pathophysiology of immune complex-mediated thrombocytopenias such as heparin-induced thrombocytopenia. In this study, FcγR proteins and mRNAs in normal human megakaryocytes were examined. FcγR proteins were studied with immunocytochemical staining, dual colour flow cytometry and immunoprecipitation using monoclonal antibodies against FcγR I, FcγR II and FcγR III. FcγR mRNAs were measured with biotinylated cDNA or oligonucleotide probes using a novel quantitative in situ hybridization technique. Using these techniques, FcγR II protein and mRNA, but not FcγR I and FcγR III proteins and transcripts were detected in megakaryocytes. Further, transcript analysis showed that megakaryocytes contain only the transcript of FcγR IIA gene but no transcripts of FcγR IIB nor FcγR IIC genes; FcγR IIA transcripts with and without the transmembrane (TM) exon are present in approximately equal proportions. In contrast, neutrophils and macrophages also contain FcγR IIA transcript but FcγR IIA transcript with the TM exon predominates suggesting cell lineage-specific FcγR IIA expression. FcγR IIA transcript lacking the TM exon predicts the presence of a potential soluble form of FcγR in platelets and megakaryocytes which may have a physiological role as it can compete with the membrane-bound FcγR IIA for binding of IgG-containing immune complexes and thus protect these cells from excessive binding and injurious effects of immune complexes.